INSPIRE CAPITAL
Inspire Capital develops a financial platform that offers insurance and other financial services. It helps users to interact with financial experts and get recommendations based on their profile, allowing users to choose a correct insurance policy according to their requirement.
INSPIRE CAPITAL
Industry:
Financial Services Insurance Software
Founded:
2013-01-01
Address:
Lake Ozark, Missouri, United States
Country:
United States
Website Url:
http://www.inspiremo.com
Total Employee:
1+
Status:
Closed
Total Funding:
800 K USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator
Similar Organizations
AIX
AIX is a digital platform that provides alternative investments, financial technology and user experience services to advisors and dealers.
Asset-Map
A visual communication tool for Financial Professionals to create a simple illustration of their clients complete financial landscape.
Tuned
The all-in-one trading platform to create, automate, and monetize strategies.
Founder
Official Site Inspections
http://www.inspiremo.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inspire Capital"
Home - InspireMD
Your new layer of defense against the significant risk of plaque prolapse and embolizationSee details»
InspireMD - Crunchbase Company Profile & Funding
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.See details»
InspireMD - Overview, News & Similar companies | ZoomInfo.com
View InspireMD (www.inspiremd.com) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
NAMSA and InspireMD Announce Strategic Outsourcing …
Sep 8, 2022 NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc. (Nasdaq: NSPRSee details»
InspireMD Announces Expected Retirement of its CFO Craig Shore …
Dec 12, 2024 On behalf of the entire InspireMD organization and Board of Directors, I would like to thank Craig for his contribution to our success for the past 15 years.See details»
InspireMD Announces Senior Leadership Changes to Support
Oct 3, 2023 InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, …See details»
Marvin Slosman - InspireMD | LinkedIn
Marvin L. Slosman is the Chief Executive Officer of InspireMD (Nasdaq: NSPR), a… · Experience: InspireMD · Education: University of Chicago · Location: Miami · 500+ connections on LinkedIn ...See details»
InspireMD Announces Expected Retirement of its CFO Craig Shore …
Miami, Florida — December 12, 2024 – InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today …See details»
InspireMD Announces Expected Retirement of its CFO Craig Shore …
MIAMI, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today …See details»
InspireMD and NAMSA Join Forces to Pioneer Pivotal Clinical Trial …
Feb 13, 2025 In an exciting development for the medical technology landscape, InspireMD, Inc. (NASDAQ: NSPR), a trailblazer in carotid stenting solutions, has announced a strategic …See details»
InspireMD Announces Establishment of Global Headquarters in …
Oct 15, 2024 Marvin Slosman, Chief Executive Officer of InspireMD, stated, “The establishment of our new headquarters location in the U.S. represents a significant step as we prepare for …See details»
InspireMD - Contacts, Employees, Board Members, Advisors
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.See details»
InspireMD CFO to Retire After 15 Years Amid Crucial FDA Approval ...
Dec 12, 2024 InspireMD announces CFO transition as company approaches potential FDA approval for its CGuard™ stent system in 2025. Key executive to assist in leadership handover.See details»
Vince Turturro - Head of US Operations - InspireMD | LinkedIn
Head of US Operations InspireMD Aug 2024 - Present 11 months Miami, Florida, United States Leading all operational activities to establish commercial distribution and headquarters in the …See details»
InspireMD Announces Establishment of Global Headquarters in …
Miami, Florida — October 15, 2024 – InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today …See details»
InspireMD and NAMSA Collaborate on CGUARDIANS II Study for …
Feb 13, 2025 InspireMD is collaborating with NAMSA, a MedTech Contract Research Organization, to conduct the study. What is the goal of InspireMD's CGuard Prime carotid …See details»
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal …
Feb 13, 2025 About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing …See details»
InspireMD Announces Establishment of Global Headquarters in …
MIAMI, Oct. 15, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today …See details»
InspireMD, Inc. (InspireMD, Inc.) - 药物管线_专利_临床试验_投融营收
May 7, 2025 About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing …See details»
SECURITIES AND EXCHANGE COMMISSION - inspiremd.com
Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 29,689,857 shares of common stock outstanding of the …See details»